Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Roussel Uclaf reports agents for BPH

March 11, 1997

New selective alpha1a/A-antagonist from Abbott

March 10, 1997

Pharmacokinetic-pharmacodynamic interactions between terazosin and finasteride

March 3, 1997

Agents for urinary incontinence from Nippon Shinyaku

Feb. 28, 1997

Positive clinical results for doxazosin as BPH Rx

Feb. 21, 1997

Agents for BPH disclosed by Merck & Co.

Feb. 19, 1997

Natural 5alpha-reductase inhibitors discovered at Taisho

Feb. 10, 1997

Dual-action compounds for BPH described by Zeria

Feb. 10, 1997

Cypress awarded grant for research related to its PROSORBA Column

Feb. 7, 1997

Tanabe Seiyaku discloses novel antinephritic compounds

Feb. 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
FDA says yes to Cytokinetics’ aficamten, now Myqorzo, in oHCM
BioWorld
Cytokinetics Inc. scored U.S. FDA marketing clearance Dec. 19 for Myqorzo (aficamten) 5-mg, 10-mg, 15-mg, and 20-mg tablets to improve functional capacity and...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....